Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
about
Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention SolutesRule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Application of metabolomics: Focus on the quantification of organic acids in healthy adultsMetabolomics and renal disease.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyUremic Solutes in Chronic Kidney Disease and Their Role in ProgressionIndoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.Protein Nutrition and Malnutrition in CKD and ESRD.New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.NMR metabolomics of renal cancer: an overview.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Metabonomic biomarkers for risk factors of chronic kidney disease.Metabolomics for clinical use and research in chronic kidney disease.Gut microbiome in chronic kidney disease: challenges and opportunities.Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study.Epigenetic modification of nucleic acids: from basic studies to medical applications.Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.A Systems-Level View of Renal Metabolomics.GC-MS-based urinary organic acid profiling reveals multiple dysregulated metabolic pathways following experimental acute alcohol consumption.Metabolite profiling study on the toxicological effects of polybrominated diphenyl ether in a rat model.
P2860
Q26784008-26E1BF9E-999C-4576-B1D5-81E14ABC51D8Q31143152-3457CA9C-0BAF-4BCD-9525-40D4DFBB764DQ33613115-4C75E92B-B421-4EAF-B46A-004A6390D0CCQ33783924-7A2E2947-907A-42CA-BCE4-A48DACAE844DQ35778649-08BA1B9D-AF88-4642-9B72-FF61FA235095Q35891553-AE5752A4-F408-4A70-8727-94054B7A102CQ36235662-0F0A72FD-3618-46DC-8665-569854202945Q36260141-75EA3B40-8CBD-41A5-AB17-9B358C87CB93Q36745803-130A1840-C97E-4C0C-8417-6ABCCD248D92Q37724958-86C1AA8C-1988-454B-B474-3B12FBA897FDQ37729646-00775C4B-082C-43FF-AE35-5D7F25E049F4Q38274050-BA0BA6E1-F0BB-47EA-8CB0-86D022B918F7Q38591205-3EE303F2-1258-4E39-99A1-BFF37995782DQ38636372-4E7FEE94-BC83-4081-BF6A-710DE372DB86Q38741939-8DE57F7D-9EDF-4330-BD51-D924AA9BAC32Q38750287-0AE660C5-8ACD-4586-8D11-1FC61D24D531Q38836354-AF32BC7C-9246-44FD-8156-EDFDFF9FD1FEQ39023043-7B24F9E1-BF93-43E3-8263-35E021611EF3Q39206156-14FDEEA7-EAF6-4D7C-A1F1-88FE8F24D1F0Q46673943-00CE308B-C889-4D9C-8036-46E748E53083Q51732046-03033916-4E7E-4080-9997-80811F822539Q52336692-F1FF30DA-9752-4849-85D6-7FC2CFBA147EQ52595334-DD9064BA-A8B7-409D-834D-2D81D961F2A8Q52673597-AB96C09E-8AA8-4EC1-8507-AAB665280F51
P2860
Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Optimized metabolomic approach ...... ronic kidney disease patients.
@ast
Optimized metabolomic approach ...... ronic kidney disease patients.
@en
Optimized metabolomic approach ...... ronic kidney disease patients.
@nl
type
label
Optimized metabolomic approach ...... ronic kidney disease patients.
@ast
Optimized metabolomic approach ...... ronic kidney disease patients.
@en
Optimized metabolomic approach ...... ronic kidney disease patients.
@nl
prefLabel
Optimized metabolomic approach ...... ronic kidney disease patients.
@ast
Optimized metabolomic approach ...... ronic kidney disease patients.
@en
Optimized metabolomic approach ...... ronic kidney disease patients.
@nl
P2093
P2860
P1433
P1476
Optimized metabolomic approach ...... ronic kidney disease patients.
@en
P2093
Henricus A M Mutsaers
Jack F M Wetzels
Joost G Hoenderop
Lambertus P van den Heuvel
Martijn J G Wilmer
Ron A Wevers
Rosalinde Masereeuw
Udo F H Engelke
P2860
P304
P356
10.1371/JOURNAL.PONE.0071199
P407
P577
2013-08-02T00:00:00Z